Cargando…
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840921/ https://www.ncbi.nlm.nih.gov/pubmed/29510782 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.9.18-00086 |
| _version_ | 1783304667188428800 |
|---|---|
| author | Rondy, Marc Kissling, Esther Emborg, Hanne-Dorthe Gherasim, Alin Pebody, Richard Trebbien, Ramona Pozo, Francisco Larrauri, Amparo McMenamin, Jim Valenciano, Marta |
| author_facet | Rondy, Marc Kissling, Esther Emborg, Hanne-Dorthe Gherasim, Alin Pebody, Richard Trebbien, Ramona Pozo, Francisco Larrauri, Amparo McMenamin, Jim Valenciano, Marta |
| author_sort | Rondy, Marc |
| collection | PubMed |
| description | Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, −42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates. |
| format | Online Article Text |
| id | pubmed-5840921 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | European Centre for Disease Prevention and Control (ECDC) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58409212018-03-23 Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies Rondy, Marc Kissling, Esther Emborg, Hanne-Dorthe Gherasim, Alin Pebody, Richard Trebbien, Ramona Pozo, Francisco Larrauri, Amparo McMenamin, Jim Valenciano, Marta Euro Surveill Rapid Communication Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, −42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates. European Centre for Disease Prevention and Control (ECDC) 2018-03-01 /pmc/articles/PMC5840921/ /pubmed/29510782 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.9.18-00086 Text en This article is copyright of The Authors, 2018. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
| spellingShingle | Rapid Communication Rondy, Marc Kissling, Esther Emborg, Hanne-Dorthe Gherasim, Alin Pebody, Richard Trebbien, Ramona Pozo, Francisco Larrauri, Amparo McMenamin, Jim Valenciano, Marta Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_full | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_fullStr | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_full_unstemmed | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_short | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| title_sort | interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five european studies |
| topic | Rapid Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840921/ https://www.ncbi.nlm.nih.gov/pubmed/29510782 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.9.18-00086 |
| work_keys_str_mv | AT rondymarc interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT kisslingesther interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT emborghannedorthe interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT gherasimalin interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT pebodyrichard interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT trebbienramona interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT pozofrancisco interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT larrauriamparo interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT mcmenaminjim interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT valencianomarta interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies AT interim201718influenzaseasonalvaccineeffectivenesscombinedresultsfromfiveeuropeanstudies |